GutierrezCA. Sildenafil-simvastatin interaction: possible cause of rhabdomyolysis?Am Fam Physician. 2001;63:636-637.
2.
PennisiGVacanteMRussoCMalaguarneraM. Rhabdomyolysis induced by rosuvastatin and sildenafil. South Med J. 2010;103:1052-1054. doi:10.1097/SMJ.0b013e3181f0e89c
3.
HornJRHanstenPDChanLN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-680. doi:10.1345/aph.1H423
4.
HirotaTIeiriI. Drug-drug interactions that interfere with statin metabolism. Expert Opin Drug Metab Toxicol. 2015;11:1435-1447. doi:10.1517/17425255.2015.1056149
5.
BellostaSCorsiniA. Statin drug interactions and related adverse reactions: an update. Expert Opin Drug Saf. 2018;17:25-37. doi:10.1080/14740338.2018.1394455
6.
ThompsonPDPanzaGZaleskiATaylorB. Statin-associated side effects. J Am Coll Cardiol. 2016;67:2395-2410. doi:10.1016/j.jacc.2016.02.071
7.
NakakariyaMGotoAAmanoN. Appropriate risk criteria for OATP inhibition at the drug discovery stage based on the clinical relevancy between OATP inhibitors and drug-induced adverse effect. Drug Metab Pharmacokinet. 2016;31:333-339. doi:10.1016/j.dmpk.2016.05.003
8.
TreiberASchneiterRHäuslerSStiegerB. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos. 2007;35:1400-1407. doi:10.1124/dmd.106.013615
9.
ChungMDiRicoACalcagniAMessigMScottR. Lack of a drug interaction between sildenafil and atorvastatin. J Clin Pharmacol. 2000;40:1057.
10.
OhDJ. Sildenafil overdose can cause rhabdomyolysis and subjective visual perception changes. Nephrology (Carlton). 2014;19:258. doi:10.1111/nep.12197
